 |
Previous Article | Next Article 
The Journal of Neuroscience, December 1, 1998, 18(23):10078-10089
Serotonin1B Receptor Stimulation Enhances Cocaine
Reinforcement
Loren H.
Parsons,
Friedbert
Weiss, and
George F.
Koob
Department of Neuropharmacology, Division of Psychopharmacology,
The Scripps Research Institute, La Jolla, California 92037
The effects of serotonin1B
[5-hydroxytryptamine1B (5-HT1B)]
receptor activation on cocaine reinforcement were investigated using
intravenous cocaine self-administration by rats. The 5-HT1B receptor agonists 5-methoxy-3-1,2,3,6-tetrahydro-4-pyridinyl-1H-indole (RU 24969) (0.3-3 mg/kg),
3-(1,2,5,6-tetrahydro-4-pyridyl)-5-propoxypyrrolo[3,2-b]pyridine (CP
94,253) (0.3-3 mg/kg), and
3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyridine (CP
93,129) (3 and 10 µg, i.c.v.) each dose-dependently
reduced the self-administration of a cocaine dose on the descending
limb of the fixed-ratio 5 (FR-5) cocaine dose-effect function,
in a manner similar to the effect produced by increasing the unit dose of cocaine. In addition, each of these 5-HT1B agonists
lowered the threshold dose of cocaine that supported
self-administration. These results are consistent with a
5-HT1B agonist-induced potentiation of cocaine
reinforcement. On a progressive ratio schedule of reinforcement, RU
24969 and CP 94,253 dose-dependently (0.3-3 mg/kg) increased the
highest completed ratio for cocaine self-administration, again by
producing behavioral alterations similar to those induced by increasing
the unit dose of cocaine. The effect of CP 94,253 was dose-dependently
blocked by the 5-HT1B/1D receptor partial agonist 2'-methyl-4'-(5-methyl[1,2,4]oxadiazol-3-yl)-biphenyl-4-carboxylic acid[4-methodoxy-3-(4-methyl-piperazin-1-yl)-phenyl]-amide (GR 127,935) (0.3-10 mg/kg) but was unaffected by the
5-HT1A receptor antagonist
4-iodo-N-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl- benzamide (p-MPPI; 1-10 mg/kg). Self-administration behavior was not maintained when either RU 24969 or CP 94,253 was substituted for
cocaine, indicating that these 5-HT1B agonists do not
produce significant reinforcing effects alone. Together, these findings indicate that 5-HT1B receptor stimulation facilitates the
reinforcing properties of cocaine. These results are in opposition to
recent findings with 5-HT1B receptor knock-out mice and may
have important ontogenic implications in the area of drug abuse research.
Key words:
cocaine; self-administration; 5-HT1B; 5-HT1A; RU 24969; CP 94,253; CP 93,129; GR 127,935; 8-OH-DPAT; p-MPPI; progressive ratio
Copyright © 1998 Society for Neuroscience 0270-6474/98/182310078-12$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
T. S. Hnasko, B. N. Sotak, and R. D. Palmiter
Cocaine-Conditioned Place Preference by Dopamine-Deficient Mice Is Mediated by Serotonin
J. Neurosci.,
November 14, 2007;
27(46):
12484 - 12488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. O'Dell and L. H. Parsons
Serotonin1B Receptors in the Ventral Tegmental Area Modulate Cocaine-Induced Increases in Nucleus Accumbens Dopamine Levels
J. Pharmacol. Exp. Ther.,
November 1, 2004;
311(2):
711 - 719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Neumaier, E. S. Vincow, A. Arvanitogiannis, R. A. Wise, and W. A. Carlezon Jr
Elevated Expression of 5-HT1B Receptors in Nucleus Accumbens Efferents Sensitizes Animals to Cocaine
J. Neurosci.,
December 15, 2002;
22(24):
10856 - 10863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Rocha, E. H. Goulding, L. E. O'Dell, A. N. Mead, N. G. Coufal, L. H. Parsons, and L. H. Tecott
Enhanced Locomotor, Reinforcing, and Neurochemical Effects of Cocaine in Serotonin 5-Hydroxytryptamine 2C Receptor Mutant Mice
J. Neurosci.,
November 15, 2002;
22(22):
10039 - 10045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Czoty, B. C. Ginsburg, and L. L. Howell
Serotonergic Attenuation of the Reinforcing and Neurochemical Effects of Cocaine in Squirrel Monkeys
J. Pharmacol. Exp. Ther.,
March 1, 2002;
300(3):
831 - 837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Sora, F. S. Hall, A. M. Andrews, M. Itokawa, X.-F. Li, H.-B. Wei, C. Wichems, K.-P. Lesch, D. L. Murphy, and G. R. Uhl
Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference
PNAS,
April 24, 2001;
98(9):
5300 - 5305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jones and J. A. Kauer
Amphetamine Depresses Excitatory Synaptic Transmission via Serotonin Receptors in the Ventral Tegmental Area
J. Neurosci.,
November 15, 1999;
19(22):
9780 - 9787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. D. Volkow, G.-J. Wang, J. S. Fowler, J. Logan, S. J. Gatley, C. Wong, R. Hitzemann, and N. R. Pappas
Reinforcing Effects of Psychostimulants in Humans Are Associated with Increases in Brain Dopamine and Occupancy of D2 Receptors
J. Pharmacol. Exp. Ther.,
October 1, 1999;
291(1):
409 - 415.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. S. Lorrain, J. V. Riolo, L. Matuszewich, and E. M. Hull
Lateral Hypothalamic Serotonin Inhibits Nucleus Accumbens Dopamine: Implications for Sexual Satiety
J. Neurosci.,
September 1, 1999;
19(17):
7648 - 7652.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|